Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 21, 2017
Pharmacy Choice - Pharmaceutical News - AMICUS THERAPEUTICS,INC. (NASDAQ:FOLD) Files An 8-K Other Events - September 21, 2017

Pharmacy News Article

 5/19/17 - AMICUS THERAPEUTICS,INC. (NASDAQ:FOLD) Files An 8-K Other Events

AMICUS THERAPEUTICS,INC. (NASDAQ:FOLD) Files An 8-K Other Events

Item 8.01. Other Events.

On May19, 2017, Amicus Therapeutics,Inc. (the Company) issued a
press release announcing the planned analysis of primary
endpoints in its Phase 3 Epidermolysis Bullosa Study. A copy of
this press release is attached hereto as Exhibit99.1.

Item 9.01. Financial Statements and Exhibits.

(d)Exhibits: The ExhibitIndex annexed hereto is incorporated
herein by reference.

Exhibit No.

Description

99.1

Press Release dated May19, 2017 titled Amicus Therapeutics
Announces Planned Analysis of Primary Endpoints in Phase 3
Epidermolysis Bullosa Study.

About AMICUS THERAPEUTICS,INC. (NASDAQ:FOLD)
Amicus Therapeutics, Inc. is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living with devastating rare and orphan diseases. Its lead product, migalastat HCl is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease. Its pipeline also includes SD-101, which is a product candidate in late-stage development, as a potential first-to-market therapy for the chronic, rare connective tissue disorder Epidermolysis Bullosa (EB). It is also leveraging its Chaperone-Advanced Replacement Therapy (CHART) platform technologies to develop ERT products for Pompe disease, Fabry disease, and potentially other lysosomal storage disorders (LSDs). The Company is also investigating preclinical and discovery programs in other rare and devastating diseases, including cyclin-dependent kinase-like 5 (CDKL5) deficiency. AMICUS THERAPEUTICS,INC. (NASDAQ:FOLD) Recent Trading Information
AMICUS THERAPEUTICS,INC. (NASDAQ:FOLD) closed its last trading session up +0.17 at 7.74 with 2,472,413 shares trading hands.

The post AMICUS THERAPEUTICS,INC. (NASDAQ:FOLD) Files An 8-K Other Events appeared first on Market Exclusive.



© Market Exclusive 2017

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Sep 21: Biosimilar Drugs: Legal, Regulatory & Safety Considerations
Last Chance
Sep 22: Influenza 2017-2018: An Update on Prevention and Treatment
Sep 24: Using Effective Communication to Reduce Medication Errors
Sep 25: Management of Major Depressive Disorders
Sep 26: Vitamins, Minerals, and Electrolytes in Older Adults
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415